Vanda Pharmaceuticals Income Statement (2009-2025) | VNDA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	62.67M	67.90M	70.09M	68.02M	60.19M	64.39M	65.32M	64.48M	62.50M	46.06M	38.81M	45.27M	47.46M	50.47M	47.65M	53.19M	50.04M	52.59M	56.26M	57.22M
Cost of Revenue (Quarter)	6.03M	6.57M	6.80M	6.24M	5.67M	6.06M	6.32M	6.24M	4.77M	3.50M	3.06M	3.46M	3.44M	2.73M	2.55M	2.59M	3.52M	2.74M	2.95M	3.83M
Gross Profit (Quarter)	56.64M	61.33M	63.30M	61.78M	54.53M	58.33M	59.00M	58.24M	57.72M	42.56M	35.75M	41.81M	44.02M	47.74M	45.10M	50.59M	46.52M	49.85M	53.30M	53.38M
Operating items
Amortization - Intangibles (Quarter)	0.40M	0.40M	0.37M	0.37M	0.40M	0.38M	0.40M	0.42M	0.40M	0.40M	0.38M	0.99M	2.02M	1.75M	1.80M	1.77M	1.80M	1.80M	1.75M	1.75M
Depreciation & Amortization - Total (Quarter)	0.34M	0.34M	0.34M	0.34M	0.32M	0.31M	0.30M	0.28M	0.29M	0.22M	0.20M	0.20M	0.21M	0.22M	0.22M	0.22M	0.23M	0.27M	0.30M	0.30M
Research & Development (Quarter)	16.13M	20.25M	19.65M	19.33M	20.97M	21.49M	24.86M	18.45M	19.24M	16.65M	16.60M	24.34M	21.15M	16.66M	16.78M	19.84M	35.71M	21.99M	22.56M	29.01M
Selling, General & Administrative (Quarter)	29.80M	28.35M	32.46M	33.45M	40.85M	33.00M	29.85M	32.78M	36.10M	28.40M	24.77M	23.61M	30.09M	39.47M	37.57M	39.28M	50.08M	64.62M	60.27M	62.98M
Other Operating Expenses (Quarter)	6.05M	6.59M	6.83M	6.27M	5.72M	6.13M	6.40M	6.33M	4.86M	3.65M	3.24M	4.21M	5.25M	4.27M	4.09M	4.12M	5.04M	4.22M	4.41M	5.28M
Operating Expenses (Quarter)	52.33M	55.53M	59.28M	59.38M	67.86M	60.93M	61.41M	57.85M	60.49M	48.92M	44.81M	52.37M	56.70M	60.62M	58.65M	63.46M	91.07M	91.09M	87.54M	97.57M
Operating Income (Quarter)	10.34M	12.37M	10.82M	8.64M	-7.67M	3.46M	3.91M	6.63M	2.00M	-2.87M	-6.00M	-7.09M	-9.23M	-10.15M	-11.00M	-10.28M	-41.03M	-38.50M	-31.28M	-40.35M
EBIT (Quarter)	10.34M	12.37M	10.82M	8.64M	-7.67M	3.46M	3.91M	6.63M	2.00M	-2.87M	-6.00M	-7.09M	-9.23M	-10.15M	-11.00M	-10.28M	-41.03M	-38.50M	-31.28M	-40.35M
Non-operating items
Interest & Investment Income (Quarter)
Net income details
EBT (Quarter)	10.43M	12.60M	10.72M	8.61M	-7.56M	3.79M	5.46M	9.61M	5.53M	2.59M	-0.12M	-1.66M	-4.66M	-5.52M	-6.24M	-6.50M	-37.37M	-34.89M	-28.39M	-38.00M
Tax Provisions (Quarter)	1.80M	3.00M	2.95M	1.51M	-1.10M	1.22M	2.20M	2.75M	2.28M	1.10M	-0.26M	0.74M	-0.52M	-1.00M	-0.90M	-1.62M	-7.90M	-7.68M	-5.80M	103.23M
Profit After Tax (Quarter)	8.65M	9.65M	7.77M	7.08M	-6.43M	2.57M	3.27M	6.86M	3.25M	1.52M	0.14M	-2.40M	-4.15M	-4.52M	-5.32M	-4.91M	-29.49M	-27.21M	-22.59M	-141.19M
Income from Continuing Operations (Quarter)	8.63M	9.60M	7.77M	7.10M	-6.46M	2.57M	3.26M	6.86M	3.25M	1.49M	0.14M	-2.40M	-4.15M	-4.52M	-5.34M	-4.88M	-29.47M	-27.21M	-22.59M	-141.23M
Consolidated Net Income (Quarter)	8.63M	9.60M	7.77M	7.10M	-6.46M	2.57M	3.26M	6.86M	3.25M	1.49M	0.14M	-2.40M	-4.15M	-4.52M	-5.34M	-4.88M	-29.47M	-27.21M	-22.59M	-141.23M
Income towards Parent Company (Quarter)	8.63M	9.60M	7.77M	7.10M	-6.46M	2.57M	3.26M	6.86M	3.25M	1.49M	0.14M	-2.40M	-4.15M	-4.52M	-5.34M	-4.88M	-29.47M	-27.21M	-22.59M	-141.23M
Net Income towards Common Stockholders (Quarter)	8.63M	9.60M	7.77M	7.10M	-6.46M	2.57M	3.26M	6.86M	3.25M	1.49M	0.14M	-2.40M	-4.15M	-4.52M	-5.34M	-4.88M	-29.47M	-27.21M	-22.59M	-141.23M
Additional items
EPS (Basic) (Quarter)	0.16	0.17	0.14	0.13	-0.11	0.05	0.06	0.12	0.06	0.03	0.00	-0.05	-0.07	-0.08	-0.09	-0.09	-0.50	-0.46	-0.38	-2.39
EPS (Weighted Average and Diluted) (Quarter)	0.15	0.17	0.14	0.12	-0.11	0.05	0.06	0.12	0.06	0.03	0.00	-0.05	-0.07	-0.08	-0.09	-0.09	-0.50	-0.46	-0.38	-2.39
Shares Outstanding (Weighted Average) (Quarter)	55.15M	55.37M	55.67M	55.55M	56.11M	56.31M	56.57M	56.46M	57.01M	57.23M	57.33M	57.38M	57.76M	57.99M	58.10M	58.15M	58.53M	58.76M	59.09M	58.93M
Shares Outstanding (Diluted Average) (Quarter)	56.51M	56.71M	56.82M	56.92M	56.11M	56.31M	56.40M	56.98M	57.40M	57.47M	57.51M	57.56M	57.76M	57.99M	58.10M	58.15M	58.53M	58.99M	58.87M	58.93M
EBITDA (Quarter)	10.69M	12.71M	11.16M	8.97M	-7.35M	3.77M	4.21M	6.91M	2.29M	-2.64M	-5.79M	-6.89M	-9.03M	-9.93M	-10.78M	-10.06M	-40.80M	-38.24M	-30.98M	-40.05M
Tax Rate (Quarter)	17.26%	23.80%	27.52%	17.56%	14.54%	32.08%	40.29%	28.63%	41.17%	42.44%	214.17%	-44.49%	11.11%	18.13%	14.41%	24.95%	21.14%	22.01%	20.44%	-271.64%

Research Tools

Vanda Pharmaceuticals Income Statement (2009-2025) | VNDA

Create an account

Sign In

Reset Password